Concepts (228)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Decision Making | 23 | 2023 | 189 | 6.150 |
Why?
|
Cannabis | 14 | 2023 | 75 | 5.440 |
Why?
|
Marijuana Abuse | 14 | 2021 | 83 | 4.930 |
Why?
|
Conduct Disorder | 6 | 2021 | 47 | 4.120 |
Why?
|
Neuropsychological Tests | 37 | 2022 | 255 | 4.110 |
Why?
|
Marijuana Smoking | 8 | 2018 | 82 | 3.110 |
Why?
|
Substance-Related Disorders | 27 | 2021 | 685 | 3.040 |
Why?
|
Adolescent Behavior | 6 | 2021 | 243 | 2.990 |
Why?
|
Brain | 22 | 2022 | 1268 | 2.810 |
Why?
|
Risk-Taking | 10 | 2019 | 435 | 2.680 |
Why?
|
Gambling | 8 | 2023 | 15 | 2.230 |
Why?
|
Adolescent | 36 | 2023 | 5035 | 2.140 |
Why?
|
Cognition | 16 | 2022 | 373 | 2.090 |
Why?
|
Cognition Disorders | 13 | 2013 | 233 | 1.890 |
Why?
|
Sex Characteristics | 8 | 2021 | 213 | 1.790 |
Why?
|
Sexual Behavior | 5 | 2018 | 587 | 1.680 |
Why?
|
Longitudinal Studies | 13 | 2023 | 841 | 1.640 |
Why?
|
Humans | 92 | 2023 | 34853 | 1.540 |
Why?
|
Reward | 4 | 2020 | 73 | 1.430 |
Why?
|
Psychomotor Performance | 8 | 2015 | 126 | 1.430 |
Why?
|
Male | 65 | 2021 | 18870 | 1.400 |
Why?
|
Female | 60 | 2021 | 19873 | 1.320 |
Why?
|
HIV Infections | 19 | 2021 | 2207 | 1.310 |
Why?
|
Motivation | 4 | 2021 | 415 | 1.270 |
Why?
|
Executive Function | 3 | 2019 | 47 | 1.250 |
Why?
|
Learning | 7 | 2018 | 108 | 1.060 |
Why?
|
Anxiety Disorders | 2 | 2018 | 281 | 1.050 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 2 | 2021 | 50 | 0.950 |
Why?
|
Impulsive Behavior | 6 | 2015 | 44 | 0.950 |
Why?
|
Attention | 6 | 2019 | 147 | 0.940 |
Why?
|
Emotions | 3 | 2021 | 204 | 0.930 |
Why?
|
Memory Disorders | 6 | 2023 | 65 | 0.880 |
Why?
|
Child | 14 | 2023 | 2875 | 0.870 |
Why?
|
HIV Seropositivity | 11 | 2016 | 182 | 0.870 |
Why?
|
Adult | 46 | 2023 | 11034 | 0.830 |
Why?
|
Mental Recall | 5 | 2016 | 73 | 0.820 |
Why?
|
Psychometrics | 7 | 2021 | 292 | 0.790 |
Why?
|
Social Environment | 2 | 2021 | 186 | 0.770 |
Why?
|
Depressive Disorder | 2 | 2018 | 166 | 0.740 |
Why?
|
Cross-Sectional Studies | 9 | 2023 | 2561 | 0.740 |
Why?
|
Schools | 1 | 2021 | 229 | 0.730 |
Why?
|
Cannabinoids | 3 | 2019 | 54 | 0.710 |
Why?
|
Amphetamine-Related Disorders | 4 | 2013 | 63 | 0.700 |
Why?
|
Medication Adherence | 2 | 2021 | 165 | 0.700 |
Why?
|
Personality Assessment | 1 | 2019 | 41 | 0.700 |
Why?
|
Multilingualism | 1 | 2019 | 31 | 0.680 |
Why?
|
Young Adult | 15 | 2019 | 4012 | 0.670 |
Why?
|
Adolescent Development | 4 | 2019 | 27 | 0.670 |
Why?
|
Mood Disorders | 1 | 2018 | 43 | 0.640 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2018 | 260 | 0.630 |
Why?
|
Methamphetamine | 4 | 2007 | 155 | 0.590 |
Why?
|
Auditory Perception | 2 | 2006 | 42 | 0.560 |
Why?
|
Anti-HIV Agents | 3 | 2017 | 394 | 0.560 |
Why?
|
Prospective Studies | 7 | 2021 | 1353 | 0.550 |
Why?
|
Mental Processes | 2 | 2012 | 15 | 0.520 |
Why?
|
Anxiety | 3 | 2017 | 705 | 0.500 |
Why?
|
Hepatitis C | 4 | 2015 | 120 | 0.480 |
Why?
|
Body Mass Index | 2 | 2019 | 775 | 0.460 |
Why?
|
Middle Aged | 29 | 2019 | 9642 | 0.460 |
Why?
|
Mental Disorders | 3 | 2021 | 285 | 0.450 |
Why?
|
Choice Behavior | 2 | 2013 | 75 | 0.450 |
Why?
|
Heroin Dependence | 4 | 2015 | 23 | 0.430 |
Why?
|
Magnetic Resonance Imaging | 5 | 2021 | 468 | 0.420 |
Why?
|
Amygdala | 3 | 2021 | 110 | 0.420 |
Why?
|
Serial Learning | 1 | 2011 | 2 | 0.410 |
Why?
|
Memory | 3 | 2013 | 165 | 0.390 |
Why?
|
Individuality | 2 | 2022 | 44 | 0.380 |
Why?
|
Analysis of Variance | 7 | 2017 | 528 | 0.370 |
Why?
|
Cyclonic Storms | 2 | 2021 | 62 | 0.370 |
Why?
|
Reproducibility of Results | 6 | 2019 | 901 | 0.330 |
Why?
|
Demography | 3 | 2006 | 167 | 0.310 |
Why?
|
Alcoholism | 3 | 2007 | 220 | 0.300 |
Why?
|
Gyrus Cinguli | 3 | 2021 | 23 | 0.300 |
Why?
|
Case-Control Studies | 4 | 2017 | 1056 | 0.290 |
Why?
|
Sex Factors | 3 | 2019 | 859 | 0.290 |
Why?
|
AIDS Dementia Complex | 2 | 2004 | 107 | 0.260 |
Why?
|
Risk Factors | 5 | 2021 | 3414 | 0.260 |
Why?
|
Follow-Up Studies | 3 | 2023 | 964 | 0.260 |
Why?
|
Depression | 3 | 2023 | 664 | 0.260 |
Why?
|
Exploratory Behavior | 1 | 2005 | 72 | 0.260 |
Why?
|
Neurotoxicity Syndromes | 1 | 2004 | 32 | 0.250 |
Why?
|
Drug Users | 3 | 2015 | 42 | 0.250 |
Why?
|
Mental Health | 2 | 2018 | 270 | 0.250 |
Why?
|
Substance Abuse, Intravenous | 1 | 2005 | 123 | 0.240 |
Why?
|
Comorbidity | 4 | 2018 | 606 | 0.240 |
Why?
|
Cubozoa | 1 | 2023 | 16 | 0.230 |
Why?
|
Stress Disorders, Post-Traumatic | 3 | 2021 | 343 | 0.230 |
Why?
|
Computers | 1 | 2003 | 27 | 0.230 |
Why?
|
Prefrontal Cortex | 2 | 2021 | 133 | 0.220 |
Why?
|
Mass Media | 1 | 2021 | 31 | 0.210 |
Why?
|
Empathy | 1 | 2021 | 26 | 0.200 |
Why?
|
Disease Management | 1 | 2021 | 61 | 0.200 |
Why?
|
Intelligence | 2 | 2019 | 12 | 0.200 |
Why?
|
Personality | 3 | 2021 | 36 | 0.190 |
Why?
|
Drug Interactions | 2 | 2015 | 137 | 0.190 |
Why?
|
Nucleus Accumbens | 1 | 2020 | 80 | 0.180 |
Why?
|
Disasters | 1 | 2020 | 64 | 0.180 |
Why?
|
Vocabulary | 1 | 2019 | 13 | 0.180 |
Why?
|
Diagnostic Tests, Routine | 1 | 2019 | 47 | 0.180 |
Why?
|
Antisocial Personality Disorder | 2 | 2010 | 17 | 0.170 |
Why?
|
Reaction Time | 4 | 2010 | 130 | 0.170 |
Why?
|
Cohort Studies | 3 | 2021 | 1422 | 0.170 |
Why?
|
Brain Mapping | 1 | 2019 | 108 | 0.170 |
Why?
|
Factor Analysis, Statistical | 1 | 2019 | 125 | 0.170 |
Why?
|
Aggression | 1 | 2019 | 75 | 0.170 |
Why?
|
Behavior, Addictive | 1 | 2018 | 33 | 0.160 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2019 | 164 | 0.160 |
Why?
|
Models, Statistical | 1 | 2019 | 171 | 0.160 |
Why?
|
Verbal Learning | 3 | 2013 | 14 | 0.160 |
Why?
|
Self Administration | 1 | 2017 | 41 | 0.150 |
Why?
|
Social Class | 1 | 2019 | 228 | 0.150 |
Why?
|
Alcohol Drinking | 1 | 2021 | 490 | 0.150 |
Why?
|
United States | 4 | 2019 | 3894 | 0.150 |
Why?
|
Regression Analysis | 3 | 2013 | 429 | 0.150 |
Why?
|
Psychoses, Substance-Induced | 1 | 2016 | 2 | 0.140 |
Why?
|
Behavior | 1 | 2016 | 32 | 0.140 |
Why?
|
Parents | 1 | 2019 | 288 | 0.140 |
Why?
|
Blood Pressure | 1 | 2019 | 613 | 0.140 |
Why?
|
Cocaine-Related Disorders | 3 | 2016 | 84 | 0.130 |
Why?
|
Age of Onset | 1 | 2015 | 98 | 0.130 |
Why?
|
Intelligence Tests | 2 | 2011 | 5 | 0.130 |
Why?
|
Reference Values | 2 | 2012 | 204 | 0.120 |
Why?
|
Visual Perception | 2 | 2016 | 63 | 0.120 |
Why?
|
Statistics as Topic | 2 | 2013 | 111 | 0.120 |
Why?
|
Socioeconomic Factors | 2 | 2015 | 1003 | 0.120 |
Why?
|
Time Factors | 3 | 2023 | 1681 | 0.120 |
Why?
|
Models, Psychological | 1 | 2013 | 120 | 0.110 |
Why?
|
Cannabidiol | 1 | 2012 | 3 | 0.110 |
Why?
|
Acquired Immunodeficiency Syndrome | 2 | 2013 | 214 | 0.110 |
Why?
|
Educational Status | 2 | 2019 | 295 | 0.110 |
Why?
|
Linear Models | 1 | 2012 | 253 | 0.100 |
Why?
|
Memory, Short-Term | 2 | 2013 | 42 | 0.100 |
Why?
|
Computer Simulation | 1 | 2013 | 347 | 0.100 |
Why?
|
Personality Inventory | 2 | 2016 | 73 | 0.100 |
Why?
|
Chicago | 2 | 2013 | 24 | 0.100 |
Why?
|
Unsafe Sex | 2 | 2010 | 161 | 0.100 |
Why?
|
Suicide, Attempted | 1 | 2012 | 88 | 0.100 |
Why?
|
Motor Skills | 1 | 2010 | 25 | 0.100 |
Why?
|
Predictive Value of Tests | 5 | 2012 | 424 | 0.100 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2020 | 18 | 0.090 |
Why?
|
Games, Experimental | 1 | 2009 | 3 | 0.090 |
Why?
|
Hippocampus | 3 | 2021 | 546 | 0.090 |
Why?
|
Affective Symptoms | 1 | 2010 | 55 | 0.090 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2011 | 251 | 0.090 |
Why?
|
Severity of Illness Index | 5 | 2016 | 608 | 0.090 |
Why?
|
Retrospective Studies | 2 | 2012 | 1961 | 0.090 |
Why?
|
Age Factors | 3 | 2006 | 1007 | 0.080 |
Why?
|
Smoking | 1 | 2015 | 903 | 0.080 |
Why?
|
Animals | 3 | 2023 | 14307 | 0.080 |
Why?
|
Homosexuality, Male | 1 | 2013 | 438 | 0.080 |
Why?
|
Stroop Test | 2 | 2021 | 2 | 0.080 |
Why?
|
Diagnostic Imaging | 1 | 2007 | 53 | 0.080 |
Why?
|
Confidence Intervals | 1 | 2007 | 151 | 0.070 |
Why?
|
Reference Standards | 1 | 2006 | 52 | 0.070 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2007 | 243 | 0.070 |
Why?
|
Temperament | 1 | 2005 | 29 | 0.060 |
Why?
|
Cross-Cultural Comparison | 1 | 2005 | 100 | 0.060 |
Why?
|
Neurodegenerative Diseases | 1 | 2006 | 119 | 0.060 |
Why?
|
Sensitivity and Specificity | 2 | 2004 | 555 | 0.060 |
Why?
|
Verbal Behavior | 1 | 2004 | 12 | 0.060 |
Why?
|
Central Nervous System Stimulants | 1 | 2006 | 165 | 0.060 |
Why?
|
Research | 1 | 2005 | 159 | 0.060 |
Why?
|
Language | 1 | 2005 | 143 | 0.060 |
Why?
|
Aspartic Acid | 1 | 2003 | 46 | 0.060 |
Why?
|
T-Lymphocytes | 1 | 2006 | 341 | 0.060 |
Why?
|
Diagnosis, Dual (Psychiatry) | 2 | 2015 | 22 | 0.060 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2003 | 24 | 0.060 |
Why?
|
Rural Population | 1 | 2023 | 253 | 0.050 |
Why?
|
Psychopathology | 1 | 2021 | 14 | 0.050 |
Why?
|
Personality Disorders | 1 | 2021 | 9 | 0.050 |
Why?
|
Incidental Findings | 1 | 2021 | 10 | 0.050 |
Why?
|
Task Performance and Analysis | 1 | 2021 | 32 | 0.050 |
Why?
|
Awareness | 1 | 2021 | 59 | 0.050 |
Why?
|
Referral and Consultation | 1 | 2021 | 110 | 0.050 |
Why?
|
Florida | 1 | 2021 | 358 | 0.050 |
Why?
|
Prevalence | 2 | 2019 | 1425 | 0.040 |
Why?
|
Aged | 2 | 2012 | 6448 | 0.040 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2019 | 59 | 0.040 |
Why?
|
National Institute of Mental Health (U.S.) | 1 | 2018 | 3 | 0.040 |
Why?
|
Habits | 1 | 2018 | 7 | 0.040 |
Why?
|
South America | 1 | 2018 | 16 | 0.040 |
Why?
|
Delphi Technique | 1 | 2018 | 22 | 0.040 |
Why?
|
North America | 1 | 2018 | 60 | 0.040 |
Why?
|
Europe | 1 | 2018 | 88 | 0.040 |
Why?
|
Asia | 1 | 2018 | 74 | 0.040 |
Why?
|
Australia | 1 | 2018 | 76 | 0.040 |
Why?
|
Compulsive Behavior | 1 | 2018 | 30 | 0.040 |
Why?
|
Nutrition Surveys | 1 | 2019 | 228 | 0.040 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 176 | 0.040 |
Why?
|
Child, Preschool | 1 | 2021 | 1318 | 0.040 |
Why?
|
Personality Tests | 1 | 2016 | 5 | 0.040 |
Why?
|
Culture | 1 | 2018 | 162 | 0.040 |
Why?
|
Legislation, Drug | 1 | 2016 | 5 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 445 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2016 | 106 | 0.030 |
Why?
|
ROC Curve | 2 | 2004 | 138 | 0.030 |
Why?
|
Wechsler Scales | 1 | 2013 | 7 | 0.030 |
Why?
|
Reading | 1 | 2013 | 12 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2013 | 79 | 0.030 |
Why?
|
Hospitals, Veterans | 1 | 2012 | 16 | 0.030 |
Why?
|
Hypertension | 1 | 2019 | 770 | 0.030 |
Why?
|
Association Learning | 1 | 2012 | 29 | 0.030 |
Why?
|
Antiviral Agents | 1 | 2013 | 148 | 0.030 |
Why?
|
Patient Compliance | 1 | 2013 | 202 | 0.030 |
Why?
|
Algorithms | 1 | 2013 | 435 | 0.020 |
Why?
|
Avoidance Learning | 1 | 2010 | 58 | 0.020 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2010 | 94 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2010 | 111 | 0.020 |
Why?
|
Psychological Tests | 1 | 2007 | 52 | 0.020 |
Why?
|
HIV Seronegativity | 1 | 2007 | 38 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2007 | 213 | 0.020 |
Why?
|
Putamen | 1 | 2006 | 15 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2006 | 210 | 0.020 |
Why?
|
Matched-Pair Analysis | 1 | 2004 | 9 | 0.020 |
Why?
|
Area Under Curve | 1 | 2004 | 91 | 0.020 |
Why?
|
Cerebral Cortex | 1 | 2006 | 274 | 0.020 |
Why?
|
Semantics | 1 | 2004 | 26 | 0.010 |
Why?
|
Disease Progression | 1 | 2006 | 580 | 0.010 |
Why?
|
Creatine | 1 | 2003 | 8 | 0.010 |
Why?
|
Phosphocreatine | 1 | 2003 | 10 | 0.010 |
Why?
|
Inositol | 1 | 2003 | 20 | 0.010 |
Why?
|
Frontal Lobe | 1 | 2003 | 49 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2003 | 281 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2003 | 195 | 0.010 |
Why?
|
Blotting, Western | 1 | 2004 | 834 | 0.010 |
Why?
|
Motor Activity | 1 | 2004 | 393 | 0.010 |
Why?
|
Aging | 1 | 2005 | 639 | 0.010 |
Why?
|
Chronic Disease | 1 | 2003 | 469 | 0.010 |
Why?
|